For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Accelerating BioVenture Innovation (ABI)

ABI is our 12-week course and training program in biomedical entrepreneurship. ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University. Register for ABITeam interest form